UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
Form 6-K
 
Report of Foreign Private Issuer
Pursuant to Rule 13a-16 or 15d-16 under the
Securities Exchange Act of 1934
 
August 14, 2024
 
Commission File Number 001-14978
 
SMITH & NEPHEW plc
(Registrant’s name)
 
Building 5, Croxley Park, Hatters Lane
Watford, England, WD18 8YE
 (Address of principal executive office)
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
 
Form 20-F a         Form 40-F __
 
 
 
 
 
 
SMITH & NEPHEW PLC
 
14 August 2024
 
NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.
 
1.   VESTING OF SHARE AWARDS UNDER THE GLOBAL SHARE PLAN 2020
 
On 13 August 2024, the Company received notification of the following transactions in US$0.20 ordinary shares (the "Shares") in Smith & Nephew plc (the "Company") following the vesting of awards under the Smith & Nephew Global Share Plan 2020.
 
All figures in these columns are stated to 6 decimal places where applicable.
 
i.    PARTIAL VESTING OF 2021 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
 
The awards were granted under the Global Share Plan 2020 on 13 August 2021 and vest in three equal tranches in the following three years, with the award vesting on 13 August 2024 being the final tranche.  A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
 
The following relates to individuals included in the below notification:
 
Reason for the notification
Initial notification /Amendment
Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Smith & Nephew plc
LEI
213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
 
Smith & Nephew plc ordinary shares of USD 0.20 each
 
Identification code
ISIN: GB0009223206
Nature of the transaction
Partial vesting on 13 August 2024 of Conditional Share awards granted on 13 August 2021 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability
Date of Transaction
2024 - 08 - 13
Place of Transaction
London Stock Exchange (XLON)
 
 
Name
(Position)
 
Status
 
Price (£)
 
Volume
 
Aggregated information
 
Craig Gaffin (President Orthopaedics)
 
PDMR
11.403054
595 (of which 146 were sold and 449 were retained.)
 
N/A Single Transaction
 
Alison Parkes (Chief Compliance Officer)
 
PDMR
11.403054
1,218 (of which 447 were sold and 771 were retained.)
 
N/A Single Transaction
 
 
 
ii.   PARTIAL VESTING OF 2023 CONDITIONAL AWARDS MADE UNDER THE GLOBAL SHARE PLAN 2020:
 
The awards were granted under the Global Share Plan 2020 on 11 August 2023. One third of the award vests in equal tranches over the following three years. A number of Shares were sold to cover taxation obligations arising on the vesting of the awards.
 
The following relates to individuals included in the below notification:
 
Reason for the notification
Initial notification /Amendment
Initial notification
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
Name
Smith & Nephew plc
LEI
213800ZTMDN8S67S1H61
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
Description of the financial instrument, type of instrument
 
Smith & Nephew plc ordinary shares of USD 0.20 each
 
Identification code
ISIN: GB0009223206
Nature of the transaction
Partial vesting on 11 August 2023 of Conditional Share awards granted on 11 August 2024 under the Smith & Nephew Global Share Plan 2020, and subsequent sale of shares to cover tax liability
Date of Transaction
2024 - 08 - 13
Place of Transaction
London Stock Exchange (XLON)
 
 
Name
(Position)
 
 
Status
 
Price (£)
 
Volume
 
Aggregated information
 
Rohit Kashyap
(President, Advanced Wound Management and Global Commercial Operations)
 
PDMR
11.403054
23,201 (of which 5,670 were sold and 17,531 were retained.)
 
N/A Single Transaction
 
 
 
Helen Barraclough
Company Secretary
Smith & Nephew plc
 
Tel:  +44 (0)1923 477100
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
 
 
 
Smith & Nephew plc
 
 
(Registrant)
 
 
 
 
 
 
Date: August 14, 2024
By:
/s/ Helen Barraclough
 
 
Helen Barraclough
 
 
Company Secretary
 

Smith and Nephew (NYSE:SNN)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Smith and Nephew 차트를 더 보려면 여기를 클릭.
Smith and Nephew (NYSE:SNN)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Smith and Nephew 차트를 더 보려면 여기를 클릭.